During the past decade, Premier Clinical Research Institute Inc. conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 9 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 9 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Premier Clinical Research Institute Inc." #1 sponsor was "ACADIA Pharmaceuticals Inc." with 5 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Premier Clinical Research Institute Inc." #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "KCAS Bio" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Premier Clinical Research Institute Inc." are "Schizophrenia" (6 trials), "Alzheimer Disease" (2 trials), "Depressive Disorder, Major" (2 trials), "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials) and "Parkinson Disease" (2 trials). Many other conditions were trialed in "Premier Clinical Research Institute Inc." in a lesser frequency.

Most popular intervention types in "Premier Clinical Research Institute Inc." are "Drug" (27 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Pimavanserin" (4 trials), "AVP-786" (2 trials), "BI 425809 dose 1" (2 trials) and "BI 425809 dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Premier Clinical Research Institute Inc." are 28 trials for "All" genders.

Currently, there are NaN active trials in "Premier Clinical Research Institute Inc.". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Premier Clinical Research Institute Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Premier Clinical Research Institute Inc., 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".